News

Filter

Current filters:

MorphoSys

1 to 9 of 10 results

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

20-08-2014

US biopharmaceutical firm Emergent BioSolutions and Germany’s MorphoSys have entered into an agreement…

BiotechnologyEmergent BioSolutionsES414GermanyLicensingMOR209/ES414MorphoSysOncologyProstate cancerUSA

MorphoSys closes on the alliance with Celgene

14-08-2013

German biotech firm MorphoSys (FSE: MOR) that its MOR202 alliance with Celgene (Nasdaq: CELG), the world's…

BiotechnologyCelgeneFinancialLicensingMOR202MorphoSysOncology

MorphoSys and Celgene in deal to advance MOR202 for multiple myeloma

27-06-2013

German biotech firm MorphoSys (FSE: MOR) and USA-based Celgene (Nasdaq: CELG), the world's largest independent…

BiotechnologyCelgeneEuropeLicensingMergers & AcquisitionsMOR202MorphoSysOncology

MorphoSys and Heptares collaborate to develop antibody therapeutics targeting GPCRs

13-02-2013

German biotech firm MorphoSys (FSE: MOR) and closely-held UK-based GPCR drug discovery company Heptares…

BiotechnologyHeptares TherapeuticsMorphoSysResearch

Enzon mulls sale of company; Bio-Rad to acquire business from MorphoSys

18-12-2012

USA-based Enzon Pharmaceuticals (Nasdaq: ENZN) said yesterday that its board has retained Lazard to act…

Bio-Rad LaboratoriesBiotechnologyEnzon PharmaceuticalsMergers & AcquisitionsMorphoSys

MorphoSys rises on positive mid-stage results for RA compound MOR103

24-09-2012

German biotechnology firm MorphoSys (FSE: MOR) saw its shares rise 15.1% to an 11-year high of 22.30…

BiotechnologyLicensingMOR103MorphoSysResearch

MorphoSys ups guidance, signs deal with Pfizer and earns three milestones

13-12-2010

Germany biotechnology firm MorphoSys (FSE: MOR) had a busy day last Friday, upgrading its financial forecasts,…

BiotechnologyFinancialLicensingMorphoSysPfizerPharmaceuticalResearch

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top